Showing Results for: “diabetes”

The 80th Scientific Sessions will be held online June 12-16, 2020 The American Diabetes Association® (ADA) is excited to announce that the 80th Scientific Sessions will be transformed into a virtual conference! The meeting will be held online on June 12-16, 2020. We have shifted the format out of an abundance of caution and in the interest of protecting our employees and participants, many of whom have one or more factors that place them in the “higher risk” category for COVID-19. ADA’s leadership has determined that a virtual experience is the best way to ensure that our entire community of

American Diabetes Association Opens Exhibitor Sign-Up, Welcomes Sponsors, and Announces Events at June 6 Ride The American Diabetes Association ® (ADA) has announced an expanded set of rider offerings, local sponsors, and exhibitor opportunities for the 2026 Tour de Cure ®: Finger Lakes. The annual cycling fundraiser, happening this year on June 6 at Stokoe Farms in Scottsville, brings together hundreds of individuals, families, organizations, and corporate teams to ride for people living with diabetes. Nationwide, over 40 million people have diabetes, and every 21 seconds, someone is

The American Diabetes Association® (ADA) will present the 2019 Albert Renold Award to Rudolph L. Leibel, MD. This award recognizes an individual whose career is distinguished by outstanding achievements in the training and mentorship of diabetes research scientists and in the facilitation of diabetes research. Dr. Leibel will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. Dr. Leibel is the Christopher J. Murphy Memorial Professor of Diabetes Research, Professor of Pediatrics and Medicine, Head of the

Veterans Health Administration program combining telemonitoring, self-management and medication support improves HbA1c levels within six months In a project entitled “Implementation of Intensive Telehealth Intervention for Rural Patients with Uncontrolled Diabetes,” researchers revealed improved HbA1c levels among rural patients with poorly-controlled type 2 diabetes who participated in a comprehensive telehealth program. The results were presented today at the American Diabetes Association’s® (ADA’s) 80th Virtual Scientific Sessions®. The study found a 1.36% reduction in HBA1c levels after

Eager to repeat the successes of last year's partnership, GNC, the global leader in health and wellness, and the American Diabetes Association ® (ADA) have once again teamed up to launch a national fundraising campaign aimed to support the over 38 million Americans living with diabetes and the millions more at risk. GNC customers can now participate by making donations at their local GNC store or online, with options to round up their purchase to the nearest dollar or select a donation amount of their choice. All proceeds will directly benefit the ADA, supporting their crucial work in diabetes

Common obesity drug reduced the risk of disease progression by 54% Today, a new analysis demonstrates the vascular benefits of semaglutide in patients with peripheral artery disease (PAD) and type 2 diabetes, including improvement in symptoms, quality of life, and disease progression in patients. An analysis of the STRIDE trial was presented as a late-breaking symposium at the 85th Scientific Sessions of the American Diabetes Association® (ADA) in Chicago and simultaneously published in Diabetes Care®. PAD is a serious condition impacting 230 million individuals globally and up to 30% of

Efforts to advance chronic disease prevention through enhanced education, awareness and support — kicking off during National Kidney Month Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care services, announced the expansion of a multi-year collaboration, focused on advancing chronic disease prevention, specifically addressing two of the most prevalent chronic conditions in the U.S. — diabetes and chronic kidney disease (CKD). The kick-off for this expanded effort coincides with National Kidney Month, a time when both organizations bolster

Today, The American Diabetes Association ® (ADA) announced its recognition as a winner in the 2022 Sharecare Awards in the category of chronic diseases for The Big Step Up: Detection that encourages people to take the big step up for their health. Sharecare (Nasdaq: SHCR), in association with The National Academy of Television Arts & Sciences, New York Chapter (NY NATAS), the Sharecare Awards promote and reward excellence for the best productions and programming in health and well-being. Each year for Diabetes Awareness Month, the ADA curates a national campaign geared towards motivating

The White House Office of Management and Budget (OMB) recently proposed a rewrite of the Guidance for Federal Financial Assistance, updating regulations that dictate reporting and performance requirements for federal grant recipients. The proposed rule implements many of the changes President Trump announced in an executive order, Improving Oversight of Federal Grantmaking, last August. Some of the most significant impacts of the OMB federal grant guidance are expected to fall on the U.S. Department of Health and Human Services, where biomedical research agencies like the National Institutes

Biden Administration Recognizes Obesity Drugs as Part of Covered Obesity Treatment in Proposed Rule Today the Centers for Medicare and Medicaid Services (CMS) announced they are rethinking the way the federal and state health care programs cover obesity treatment—recognizing obesity as a chronic disease. The Administration proposes to cover Food and Drug Administration (FDA) approved medications to reduce excess weight that leads to health conditions for Medicare Part D, Medicare Advantage and Medicaid beneficiaries who have obesity. Until now, breakthrough obesity medications were only